Clarus Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Clarus Therapeutics's estimated annual revenue is currently $4.2M per year.
- Clarus Therapeutics's estimated revenue per employee is $201,000
Employee Data
- Clarus Therapeutics has 21 Employees.
- Clarus Therapeutics grew their employee count by -16% last year.
Clarus Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | SVP Manufacturing and Supply | Reveal Email/Phone |
2 | VP, Sales | Reveal Email/Phone |
3 | Chief Medical Officer | Reveal Email/Phone |
4 | Senior Manager | Reveal Email/Phone |
5 | Clinical Sales Specialist | Reveal Email/Phone |
6 | Clinical Sales Specialist | Reveal Email/Phone |
Clarus Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $13.1M | 65 | 30% | N/A | N/A |
#2 | $75.6M | 376 | 7% | N/A | N/A |
#3 | $23.9M | 119 | 13% | $35M | N/A |
#4 | $12.7M | 63 | -3% | N/A | N/A |
#5 | $5.4M | 27 | -25% | N/A | N/A |
#6 | $6M | 30 | -35% | N/A | N/A |
#7 | $6.6M | 33 | -8% | N/A | N/A |
#8 | $13.5M | 67 | -3% | N/A | N/A |
#9 | $186.3M | 927 | 19% | N/A | N/A |
#10 | $4.4M | 22 | -4% | N/A | N/A |
What Is Clarus Therapeutics?
Clarus Therapeutics, Inc. is a men's specialty pharmaceutical company with a mission to help men with hypogonadism, a condition associated with a deficiency or absence of endogenous testosterone. We are working hard every day to make a difference in the lives of affected men. As a privately-held company, Clarus Therapeutics is backed by Thomas, McNerney & Partners, L.P., H.I.G. BioHealth Partners, ProQuest Investments, C-Bridge Capital Partners, LLC, BVCF Management, Ltd. and Pavilion Capital Pte Ltd. To learn more, visit clarustherapeutics.com. View our community guidelines: http://bit.ly/2H9QmH5
keywords:N/A
N/A
Total Funding
21
Number of Employees
$4.2M
Revenue (est)
-16%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Clarus Therapeutics News
NORTHBROOK -- Clarus Therapeutics Holdings, Inc., recently announced that it has received a notice of allowance from the United States...
Clarus Therapeutics Announces Notice of Allowance for Patent Claims Covering JATENZO® (testosterone undecanoate). Published: Apr 28, 2022.
Clarus Therapeutics Holdings, Inc. is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women ...
Other Companies in Northbrook
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.6M | 21 | -25% | N/A |
#2 | $1.5M | 21 | -12% | N/A |
#3 | N/A | 21 | -5% | N/A |
#4 | $4.3M | 21 | -25% | N/A |
#5 | N/A | 22 | -42% | N/A |